Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHA/688428 stock hub

SHA/688428 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHA/688428is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
23.8B
Shanghai Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHA/688428
In the news

Latest news · SHA/688428

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E131.6
P25 17.1P50 24.2P75 37.8
Trailing P/E32.6
P25 23.5P50 41.3P75 83.2
ROE10.4
P25 -0.9P50 4.1P75 8.8
ROIC26.3
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHA/688428 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
185
Groups with data
11
Currency
CNY
Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Cayman Islands
Country code
CN
Employees
1,176
Employees Change
87%
Employees Change Percent
7.99
Enterprise value
CNY 18.4B
Exchange
Shanghai Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Last refreshed
2026-05-10
Market cap
CNY 23.8B
Price
CNY 26.35
Price currency
CNY
Rev Per Employee
2,144,786.01x
Sector
Healthcare
Sic
2836
Symbol
sha/688428
Website
https://www.innocarepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
3.07%
EV Earnings
25.13x
EV/EBIT
33.97x
EV/EBITDA
28.27x
EV/FCF
-421.55x
EV/Sales
7.37x
FCF yield
-0.18%
Forward P/E
131.63x
P/B ratio
3.24x
P/E ratio
32.62x
P/S ratio
9.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
21.69%
EBITDA Margin
24.88%
Gross margin
91.36%
Gross Profit
CNY 2.3B
Gross Profit Growth
114.44%
Gross Profit Growth Q
34.97%
Gross Profit Growth3 Y
62.4%
Gross Profit Growth5 Y
117.9%
Net Income
CNY 730.3M
Net Income Growth Q
488.93%
Pretax Margin
29.51%
Profit Margin
28.95%
Profit Per Employee
CNY 621,018
ROA
3.45
Roa5y
-2.42
ROCE
6.13
ROE
10.36
Roe5y
-4.25
ROIC
26.31
Roic5y
-85.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr1y
28.75%
Cagr3y
27.34%
EPS Growth Q
500
OCF Growth Q
-92.53%
Revenue Growth
105.92x
Revenue Growth Q
38.65x
Revenue Growth3 Y
53.63x
Revenue Growth5 Y
117.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
CNY 0.25
Assets
CNY 10.4B
Cash
CNY 7.1B
Current Assets
CNY 8.2B
Current Liabilities
CNY 1.5B
Debt
CNY 1.5B
Debt EBITDA
CNY 2.33
Debt Equity
CNY 0.21
Debt FCF
CNY -35.19
Equity
CNY 7.4B
Interest Coverage
10.11
Liabilities
CNY 3B
Long Term Assets
CNY 2.2B
Long Term Liabilities
CNY 1.6B
Net Cash
CNY 5.6B
Net Cash By Market Cap
CNY 23.34
Net Cash Growth
1.76%
Net Debt EBITDA
CNY -8.86
Net Debt Equity
CNY -0.76
Tangible Book Value
CNY 7.1B
Tangible Book Value Per Share
CNY 4.02
WACC
6.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.65
Inventory Turnover
1.61
Net Working Capital
CNY 180.4M
Quick ratio
5.23
Working Capital
CNY 6.7B
Working Capital Turnover
CNY 0.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
0.97%
Payout Ratio
4.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
28.73%
200-day SMA
25.67
3Y total return
106.51%
50-day SMA
26.13
50-day SMA vs 200-day SMA
50over200
All Time High
34.02
All Time High Change
-22.55%
All Time High Date
2025-08-18
All Time Low
7.28
All Time Low Change
261.95%
All Time Low Date
2024-06-18
ATR
1.21
Beta
0.42
Ch YTD
28.41
High
27.47
High52
34.02
High52 Date
2025-08-18
High52ch
-22.55%
Low
26.25
Low52
19.36
Low52 Date
2026-01-27
Low52ch
36.11%
Ma50ch
0.83%
Price vs 200-day SMA
2.65%
RSI
42.08
RSI Monthly
62.51
RSI Weekly
52.83
Sharpe ratio
0.77x
Sortino ratio
1.36
Total Return
0.97%
Tr YTD
28.41
Tr1m
-11.22%
Tr1w
0.15%
Tr3m
9.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
CNY 547.2M
Operating margin
21.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
1,126,814,760%
Net Borrowing
226,118,084
Shares Insiders
20.72%
Shares Institutions
29.97%
Shares Qo Q
-8.7%
Shares Yo Y
-0.97%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
CNY -113.1M
Average Volume
12,271,183.85x
Bv Per Share
4.16
CAPEX
CNY -75.1M
Ch1m
-11.22
Ch1w
0.15
Ch1y
28.73
Ch3m
9.7
Ch3y
106.5
Ch6m
10.44
Change
-2.48%
Change From Open
-3.12
Close
27.02
Days Gap
0.67
Depreciation Amortization
80,429,274
Dollar Volume
307,390,668
Earnings Date
2026-04-24
EBIT
CNY 547.2M
EBITDA
CNY 627.6M
EPS
CNY 0.43
F Score
6
FCF
CNY -43.5M
FCF EV Yield
-0.24x
Financing CF
203,270,878
Fiscal Year End
December
Founded
2,015
Goodwill
3,124,706
Graham Number
12.16545
Graham Upside
-53.83
Income Tax
CNY 12M
Investing CF
-832,076,876
Is Primary Listing
0
Last Earnings Date
2026-04-24
Last Report Date
2026-03-31
Ma150
24.47
Ma150ch
7.7%
Ma20
28.72
Ma20ch
-8.26%
Net CF
-718,495,086
Next Earnings Date
2026-05-11
Open
27.2
P OCF Ratio
754
Position In Range
8.2
Ppne
729,468,201
Price Date
2026-05-08
Price EBITDA
CNY 37.96
Ptbv Ratio
3.36
Relative Volume
0.95x
Revenue
2,522,268,343x
SBC By Revenue
2.76x
Share Based Comp
69,605,162
Tax By Revenue
0.48x
Tax Rate
1.62%
Tr6m
10.44%
Volume
11,665,680
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does SHA/688428 pay a dividend?

Capital-return profile for this ticker.

Performance

SHA/688428 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+28.7%
S&P 500 1Y: n/a
3Y total return
+106.5%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SHA/688428?

Insider, institutional, and short-interest positioning.

Institutional ownership
+30.0%
Share of float held by funds and institutions
Insider ownership
+20.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-1.0%
Negative means the company is buying back shares.
Technical

SHA/688428 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.1
Neutral momentum band
Price vs 200-day MA
+2.7%
50/200-day relationship not available
Beta (5Y)
0.42
Less volatile than the market
Sharpe ratio
0.77
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHA/688428

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688428 stock rating?

sha/688428 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688428 analysis?

The full report lives at /stocks/sha/688428/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688428?

The latest report frames sha/688428 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688428 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.